To assess the antiviral versus the antitumour immune response during active VSV-GP treatment, splenocytes from mice bearing LLC1-IFNAR1−/− tumours were harvested 7 days after systemic virus treatment and analysed using an IFNγ ELISpot assay. Here, IFNAR1 is linked to neoplasm.